Israeli Biotech Files Ch. 15 To Implement Take-Private Deal

By Vince Sullivan · April 23, 2024, 6:16 PM EDT

Gamida Cell Ltd., an Israeli biotechnology company developing immunotherapy products, filed for Chapter 15 protection Monday in Delaware seeking the American court's approval of its foreign take-private proposal with unsecured lenders....

To view the full article, register now.